Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study. [PDF]
Liu L +6 more
europepmc +1 more source
Multimodal imaging findings of primary renal well-differentiated neuroendocrine tumors (carcinoid): a case report and literature review. [PDF]
Wei B, Chen Y, Chen Y, Zhang S.
europepmc +1 more source
Ginsenoside Rb1 attenuates erythropoietin-exacerbated vascular calcification in chronic kidney disease through BMP2-dependent Smad1/5/9 inhibition. [PDF]
Li X +6 more
europepmc +1 more source
Combining corticosteroid therapies during preterm ventilation: balancing pulmonary benefits and neuroinflammatory risks. [PDF]
Razak A, Malhotra A.
europepmc +1 more source
Immunomodulatory effect of CD71<sup>+</sup> erythroid cells in patients with kidney failure. [PDF]
Zamani B +6 more
europepmc +1 more source
Treatment of EPOR-rearranged acute lymphoblastic leukemia with ruxolitinib: case reports and review of the literature. [PDF]
Dai Y +6 more
europepmc +1 more source
Erythropoietin and Erythropoietin Receptor Expression in Vestibular Schwannoma
Diensthuber, M +3 more
openaire +1 more source
Related searches:
Erythropoietin and Erythropoietin Receptor
Growth Factors, 1999(1999). Erythropoietin and Erythropoietin Receptor. Growth Factors: Vol. 17, No. 1, pp. 25-35.
P A, Tilbrook, S P, Klinken
openaire +2 more sources
The erythropoietin (epo) receptor is a member of the cytokine receptor family. It is expressed almost exclusively on erythroid precursor cells and controls the development of red blood cells. The epo receptor has no intrinsic kinase activity, but binds intracellular tyrosine kinases to elicit its signals.
P A, Tilbrook, S P, Klinken
openaire +2 more sources
Erythropoietin and Erythropoietin Receptor in Colorectal Cancer
International Journal of Surgical Pathology, 2008Erythropoietin via erythropoietin receptor effectively prevents anemia, giving reasons for a clinical use of erythropoietin in patients with colorectal cancers. However, erythropoietin seems to promote survival of the neoplastic cells in hypoxic environment.
Anna M, Chabowska +5 more
openaire +2 more sources

